Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China flag China · Delayed Price · Currency is CNY
10.99
+0.01 (0.09%)
Apr 30, 2026, 3:00 PM CST

SHA:603998 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
219.24276.25308.46208.98399.72258.88
Trading Asset Securities
35--20.3340.3115.42
Cash & Short-Term Investments
254.24276.25308.46229.3440.03274.3
Cash Growth
35.79%-10.44%34.52%-47.89%60.42%-14.05%
Accounts Receivable
269.09267.15285.32231.09191.95254.67
Other Receivables
34.7332.5337.8713.5164.930.2
Receivables
303.82299.69376.59244.59356.85284.87
Inventory
350.59338.71376.15328.28303.4256.73
Other Current Assets
104.6199.1976.34118.4990.8150.74
Total Current Assets
1,0131,0141,138920.671,191866.63
Property, Plant & Equipment
1,1401,1431,1101,051841.25823.03
Long-Term Investments
158.29158.01239.1257.52252.97193.91
Goodwill
265.21265.21269.03274.41246.44378.73
Other Intangible Assets
254.51251.13281.59267.68273.71249.95
Long-Term Accounts Receivable
----26.3842.39
Long-Term Deferred Tax Assets
10.9211.2710.1515.64.241.53
Long-Term Deferred Charges
18.4516.3113.7718.138.0641.09
Other Long-Term Assets
194.48197.38158.31126.4478.27107.21
Total Assets
3,0563,0563,2673,0812,9222,704
Accounts Payable
163.87170.62244.26245.82165.61117.18
Accrued Expenses
27.654.09319.76294.96311.88272.16
Short-Term Debt
358.45343.63532.49309.27229.96462.95
Current Portion of Long-Term Debt
25.6565.691.1193.8820.1113.85
Current Portion of Leases
--2.022.350.4910.46
Current Income Taxes Payable
38.8450.023.8910.0525.069.89
Current Unearned Revenue
31.9429.1336.2238.9887.4735.1
Other Current Liabilities
473.89437.27158.79152.77159.02333.87
Total Current Liabilities
1,1201,1501,2991,248999.591,255
Long-Term Debt
--146.5155.11342.8927.75
Long-Term Leases
21.1422.7219.0421.310.8437.04
Long-Term Unearned Revenue
43.9544.0634.0632.8637.2253.41
Long-Term Deferred Tax Liabilities
31.4332.133.5734.5133.9227.17
Other Long-Term Liabilities
3.353.62-0.38--
Total Liabilities
1,2201,2531,5321,4921,4141,401
Common Stock
439.08439.08439.09439.73439.31429.43
Additional Paid-In Capital
151.1151.1189.63185.82163.87131.93
Retained Earnings
1,1441,122995.33849.61816.65634.76
Treasury Stock
---1-17-29.63-
Comprehensive Income & Other
-0.39-0.2-0.07-0.07-0.07-0.07
Total Common Equity
1,7341,7121,6231,4581,3901,196
Minority Interest
101.3991.15111.9130.63117.81107.6
Shareholders' Equity
1,8351,8031,7351,5891,5081,304
Total Liabilities & Equity
3,0563,0563,2673,0812,9222,704
Total Debt
405.24432.03701.15681.93594.3552.05
Net Cash (Debt)
-151-155.78-392.69-452.62-154.26-277.75
Net Cash Per Share
-0.34-0.36-0.89-1.02-0.36-0.63
Filing Date Shares Outstanding
441.96431.36439.09439.73439.31429.43
Total Common Shares Outstanding
441.96431.36439.09439.73439.31429.43
Working Capital
-106.97-136.61-160.99-327.42191.5-388.83
Book Value Per Share
3.923.973.703.323.162.79
Tangible Book Value
1,2141,1951,072916.01869.98567.36
Tangible Book Value Per Share
2.752.772.442.081.981.32
Buildings
--801.14774.18635.14529.35
Machinery
--421.59384.19309.4362.11
Construction In Progress
--262.36217.53189.65201.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.